Hospitalizations for Chronic Obstructive Pulmonary Disease Exacerbation During COVID-19

0 avis

Hospitalizations for Chronic Obstructive Pulmonary Disease Exacerbation During COVID-19

Archive ouverte

Edité par CCSD ; American Medical Association -

International audience. This cross-sectional study investigates changes in the number of chronic obstructive pulmonary disease (COPD)–related admissions before, during, and after the COVID-19 pandemic in France.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Healthcare Resource Utilisation and Costs of Mepolizumab Initiation: A 5‐Year National Cohort Analysis

Archive ouverte | Bourdin, Arnaud | CCSD

International audience

Rising total costs and mortality rates associated with admissions due to COPD exacerbations

Archive ouverte | Molinari, Nicolas | CCSD

International audience

Hospitalizations for COPD Exacerbations: Trends and Determinants of Death.

Archive ouverte | Molinari, Nicolas | CCSD

International audience

Chargement des enrichissements...

Syracuse

Hospitalizations for Chronic Obstructive Pulmonary Disease Exacerbation During COVID-19

Consulter en ligne

Suggestions

Du même auteur

Healthcare Resource Utilisation and Costs of Mepolizumab Initiation: A 5‐Year National Cohort Analysis

Rising total costs and mortality rates associated with admissions due to COPD exacerbations

Hospitalizations for COPD Exacerbations: Trends and Determinants of Death.

Liens utiles

Coordonnées

VigiPallia

Infos pratiques

Hospitalizations for Chronic Obstructive Pulmonary Disease Exacerbation During COVID-19

Consulter en ligne

Suggestions

Du même auteur

Healthcare Resource Utilisation and Costs of Mepolizumab Initiation: A 5‐Year National Cohort Analysis

Rising total costs and mortality rates associated with admissions due to COPD exacerbations

Hospitalizations for COPD Exacerbations: Trends and Determinants of Death.

Liens utiles

Coordonnées